Abstract
Rationale
Cigarette cravings are well documented during the first weeks of smoking abstinence. Treatments focus on helping smokers reduce these acute cravings. Cravings experienced later on are less well understood and may be important when considering treatment duration.
Objective
We conducted a longitudinal study of cravings over 52 weeks of smoking abstinence.
Methods
Cravings were operationalised as strength of, and time spent with, urges to smoke. These were assessed among 452 smokers quitting with behavioural support but without pharmacotherapies. Individuals maintaining abstinence were assessed at 1, 2, 3, 4, 26 and 52 weeks after quitting (n = 197, 156, 139, 131, 66 and 38, respectively). Abstinence was validated at each assessment by expired carbon monoxide. Time courses were plotted for those abstinent for 52 weeks and for those abstinent up to earlier time points. Correlations were examined between ratings of urges at consecutive time points.
Results
Ratings of strength of urges to smoke followed an exponential decline over 52 weeks of abstinence, but 6 months after quitting 13 % of ex-smokers still reported strong urges. At 12 months, no ex-smokers reported strong urges, although 34 % reported some urges. Strength of urges to smoke after 1, 2, 3 and 4 weeks of abstinence predicted strength of urges at 6 months.
Conclusions
Strength of urges to smoke decline exponentially over time following smoking cessation, though some smokers report strong urges after 6 months of abstinence, and urges are still reported by a third of smokers after 12 months. Relapse prevention treatments may need to target prolonged craving.
Similar content being viewed by others
References
Baker TB, Breslau N, Covey L, Shiffman S (2012) DSM criteria for tobacco use disorder and tobacco withdrawal: a critique and proposed revisions for DSM-5. Addiction 107:263–275
Daughton DM, Fortmann SP, Glover ED, Hatsukami DK, Heatley SA, Lichtenstein E, Repsher L, Millatmal T, Killen JD, Nowak RT, Ullrich F, Patil KD, Rennard SI (1999) The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day. Prev Med 28:113–118
Fagerström K (2012) Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. Nicotine Tob Res 14:75–78
Fletcher PD, Doll R (1969) A survey of doctors’ attitudes to smoking. Br J Prev Soc Med 23:145–153
Gritz ER, Carr CR, Marcus AC (1991) The tobacco withdrawal syndrome in unaided quitters. Br J Addict 86:57–69
Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO (1991) The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 86:1119–1127
Hendricks PS, Ditre JW, Drobes DJ, Brandon TH (2006) The early time course of smoking withdrawal effects. Psychopharmacology 187:385–396
Henningfield JE, Shiffman S, Ferguson SG, Gritz ER (2009) Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy. Pharmacol Ther 123:1–16
Herd N, Borland R, Hyland A (2009) Predictors of smoking relapse by duration of abstinence: findings from the International Tobacco Control (ITC) Four Country Survey. Addiction 104:2088–2099
Hughes JR (1992) Tobacco withdrawal in self-quitters. J Consult Clin Psychol 60:689–697
Hughes JR (2007) Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res 9:315–327
Hughes JR (2010) Craving among long-abstinent smokers: an Internet survey. Nicotine Tob Res 12:459–462
Hughes JR, Gust SW, Skoog K, Keenan R, Fenwick JW (1991) Symptoms of tobacco withdrawal: a replication and extension. Arch Gen Psychiatry 48:52–59
Hughes JR, Keely J, Naud S (2004) Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 99:29–38
Killen JD, Fortmann SP (1997) Craving is associated with smoking relapse: findings from three prospective studies. Exp Clin Psychopharmacol 5:137–142
McCarthy DE, Piasecki TM, Fiore MC, Baker TB (2006) Life before and after quitting smoking: an electronic diary study. J Abnorm Psychol 115:454–466
Piasecki TM, Fiore MC, Baker TB (1998) Profiles in discouragement: two studies of variability in the time course of smoking withdrawal symptoms. J Abnorm Psychol 107:238–251
Piasecki TM, Niaura R, Shadel WG, Abrams D, Goldstein M, Fiore MC, Baker TB (2000) Smoking withdrawal dynamics in unaided quitters. J Abnorm Psychol 109:74–86
Piasecki TM, Jorenby DE, Smith SS, Fiore MC, Baker TB (2003) Smoking withdrawal dynamics: II. Improved tests of withdrawal–relapse relations. J Abnorm Psychol 112:14–27
Sayette MA, Shiffman S, Tiffany ST, Niaura RS, Martin CS, Shadel WG (2000) The measurement of drug craving. Addiction 95(Suppl 2):S189–S210
Shiffman S, Hickcox M, Paty JA, Gnys M, Kassel JD, Richards TJ (1996) Progression from a smoking lapse to relapse: prediction from abstinence violation effects, nicotine dependence, and lapse characteristics. J Consult Clin Psychol 64:993–1002
Shiffman S, Engberg JB, Paty JA, Perz WG, Gnys M, Kassel JD, Hickcox M (1997) A day at a time: predicting smoking lapse from daily urge. J Abnorm Psychol 106:104–116
Stapleton J (1998) Cigarette smoking prevalence, cessation and relapse. Stat Methods Med Res 7:187–203
Stead LF, Lancaster T (2005) Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev 2:CD001007
Tomson T, Toftgård M, Gilljam H, Helgason AR (2006) Symptoms in smokers trying to quit. Tob Induc Dis 3:44–58
Tonstad S, Tønnesen P, Hajek P, Williams KE, Billing CB, Reeves KR (2006) Varenicline Phase 3 Study Group: effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA 296:64–71
West R, Hajek P (2004) Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal. Psychopharmacology 177:195–199
West R, Russell M (1985) Pre-abstinence smoke intake and smoking motivation as predictors of severity of cigarette withdrawal symptoms. Psychopharmacology 87:334–336
West R, Ussher M (2009) Is the ten-item Questionnaire of Smoking Urges (QSU-brief) more sensitive to abstinence than shorter craving measures? Psychopharmacology 208:427–432
West R, Hajek P, Stead L, Stapleton J (2005) Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 100:299–303
West R, Ussher M, Evans M, Rashid M (2006) Assessing DSM-IV nicotine withdrawal symptoms: a comparison and evaluation of five different scales. Psychopharmacology 184:619–627
West R, May S, McEwen A, McRobbie H, Hajek P, Vangeli E (2010) A randomised trial of glucose tablets to aid smoking cessation. Psychopharmacology 207:631–635
Acknowledgments
This study was funded by the Wellcome Trust and Cancer Research UK. Dr. Ussher and Professors West and Hajek are members of the UK Centre for Tobacco Control Studies.
Conflict of interest
Professors West and Hajek undertake research and consultancy for companies that develop and manufacture smoking cessation medications. Professor West has a share of a patent in a novel nicotine delivery device. Dr. Beard has received conference funding from Pfizer. The remaining authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ussher, M., Beard, E., Abikoye, G. et al. Urge to smoke over 52 weeks of abstinence. Psychopharmacology 226, 83–89 (2013). https://doi.org/10.1007/s00213-012-2886-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-012-2886-7